In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Dynavax Technologies Corp. (NASDAQ: DVAX) closed the day trading at $11.17 down -2.19% from the previous closing price of $11.42. In other words, the price has decreased by -$2.19 from its previous closing price. On the day, 1.92 million shares were traded. DVAX stock price reached its highest trading level at $11.41 during the session, while it also had its lowest trading level at $11.1.
Ratios:
For a better understanding of DVAX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.13. For the most recent quarter (mrq), Quick Ratio is recorded 12.96 and its Current Ratio is at 13.81. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.41.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on February 01, 2024, initiated with a Neutral rating and assigned the stock a target price of $20.
On September 27, 2022, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $22.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 01 ’24 when Burgess Justin sold 20,526 shares for $12.78 per share. The transaction valued at 262,322 led to the insider holds 0 shares of the business.
Janssen Robert sold 1,500 shares of DVAX for $22,500 on Jan 04 ’24. The SVP and CMO now owns 49,925 shares after completing the transaction at $15.00 per share. On Jan 02 ’24, another insider, Novack David F, who serves as the President & COO of the company, sold 9,000 shares for $14.45 each. As a result, the insider received 130,050 and left with 3,187 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DVAX now has a Market Capitalization of 1461739776 and an Enterprise Value of 973579008. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.28 while its Price-to-Book (P/B) ratio in mrq is 2.33. Its current Enterprise Value per Revenue stands at 4.191 whereas that against EBITDA is -37.289.
Stock Price History:
Over the past 52 weeks, DVAX has reached a high of $15.15, while it has fallen to a 52-week low of $10.06. The 50-Day Moving Average of the stock is -9.00%, while the 200-Day Moving Average is calculated to be -17.45%.
Shares Statistics:
Over the past 3-months, DVAX traded about 1.96M shares per day on average, while over the past 10 days, DVAX traded about 2727380 shares per day. A total of 130.62M shares are outstanding, with a floating share count of 130.21M. Insiders hold about 0.31% of the company’s shares, while institutions hold 96.84% stake in the company. Shares short for DVAX as of 1713139200 were 18536992 with a Short Ratio of 9.48, compared to 1710460800 on 17348223. Therefore, it implies a Short% of Shares Outstanding of 18536992 and a Short% of Float of 17.31.
